HKB's Mouse Idiopathic Pulmonary Fibrosis Models provide pharmaceutical researchers with robust platforms for investigating progressive fibrotic lung disease. Our validated rodent models utilize multiple induction approaches including bleomycin instillation, silica exposure, and radiation-induced fibrosis to replicate key features of IPF including excessive collagen deposition, fibroblast proliferation, and progressive loss of lung function.
HkeyBio is a China-based, globally-focused preclinical CRO dedicated exclusively to autoimmune and allergic diseases, with a unified service network across Asia, the Americas, Europe and Australia.